Learn about steatosis, including hepatic steatosis, fatty liver disease, NAFLD, and NASH diagnosis codes (ICD-10-CM K76.0, K75.81). Find information on clinical documentation requirements for steatosis grading, liver function tests (LFTs), and imaging studies. Explore resources for healthcare professionals on managing and coding steatosis, including alcoholic fatty liver disease and nonalcoholic fatty liver disease. Understand the difference between simple steatosis and steatohepatitis, along with relevant medical terminology and clinical guidelines for accurate diagnosis and treatment.
Also known as
Other specified diseases of liver
This code specifies other liver diseases, including steatosis.
Fatty liver, not elsewhere classified
This code encompasses various fatty liver conditions like steatosis.
Diseases of liver
This range covers all liver diseases, including steatosis or fatty liver.
Other disorders of mineral metabolism
Non-alcoholic fatty liver disease may be associated with metabolic disorders.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the steatosis alcoholic?
Yes
Is fibrosis/cirrhosis present?
No
Is it related to drug/toxin?
When to use each related code
| Description |
|---|
| Fatty liver disease |
| Nonalcoholic fatty liver disease (NAFLD) |
| Nonalcoholic steatohepatitis (NASH) |
Coding steatosis without specifying alcoholic vs. non-alcoholic impacts reimbursement and data accuracy. CDI should query for etiology.
Confusing steatosis with steatohepatitis leads to incorrect coding and severity misrepresentation. CDI clarification is crucial.
Failing to code associated conditions like diabetes or obesity with steatosis impacts risk adjustment and resource allocation.
Patient presents with suspected hepatic steatosis, also known as fatty liver disease. Clinical findings suggestive of steatosis include elevated liver enzymes (ALT, AST), possible hepatomegaly on physical examination, and potential complaints of fatigue or right upper quadrant discomfort. Patient denies significant alcohol consumption, minimizing the likelihood of alcoholic fatty liver disease. Diagnostic workup may include abdominal ultrasound, liver function tests (LFTs), and potentially further imaging such as MRI or CT scan to assess the degree of fatty infiltration and rule out other liver pathologies. Differential diagnosis includes nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and other causes of hepatomegaly. Initial treatment plan focuses on lifestyle modifications including weight loss through diet and exercise, management of underlying metabolic conditions such as diabetes or hyperlipidemia, and avoidance of hepatotoxic medications. Patient education provided regarding the importance of adherence to the treatment plan to prevent progression to more severe liver disease. Follow-up scheduled to monitor liver enzyme levels and assess response to therapy. ICD-10 code K76.0 will be considered for billing and coding purposes.